| Direct-acting antivirals and host-targeting approaches against enterovirus B infections: recent advances C Tammaro, M Guida, F Appetecchia, M Biava, S Consalvi, G Poce Pharmaceuticals 16 (2), 203, 2023 | 8 | 2023 |
| Mycobacterium tuberculosis inhibitors: an updated patent review (2021–present) S Benedetta, F Vallini, M Guida, C Tammaro, M Biava, G Poce Expert Opinion on Therapeutic Patents 34 (12), 1215-1230, 2024 | | 2024 |
| Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA AO Oluwole, NV Kalmankar, M Guida, JL Bennett, G Poce, JR Bolla, ... Proceedings of the National Academy of Sciences 121 (41), e2408315121, 2024 | | 2024 |
| Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery M Guida, C Tammaro, M Quaranta, B Salvucci, M Biava, G Poce, ... Pharmaceutics 16 (6), 725, 2024 | | 2024 |
